Ahead of DHC Disrupt on October 15th, Mark Bard, co-founder and managing partner of The DHC Group, sat down with Matt Holland, COO of Healio, at this year’s Fierce Pharma Week to unpack how AI is reshaping physician trust, content, and market research. Holland shares why transparency, credibility, and recency are becoming the real currency of trust with HCPs, and previews Healio AIQ, a real-time insights engine born from watching what physicians actually ask. It’s a preview of the conversations happening at DHC Disrupt, where the industry’s most forward-thinking digital marketers will explore how AI is already changing the rules of healthcare engagement.

DHC DISRUPT 2026 is a complimentary, invite-only summit designed exclusively for pharmaceutical marketers and members of The DHC Group network.